Stocks · Healthcare · Biotechnology
Tonix Pharmaceuticals Holding Corp. TNXP
$8.91 -3.47% Close, Oct 2, 2026 · NASDAQ · Market cap $142.0M
Strong growthWeak trendExpensive vs sectorHigh risk
Next earnings report: Nov 9, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $29.1M, up 196.0% from a year earlier, accelerating from 74.8% a quarter earlier.
- Operating margin widened to -568.4% from -838.0% a year earlier.
- The diluted share count rose 127.0% in a year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 7%
- Revenue growth accelerationTop 3%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 16%
- Gross marginTop 30%
- Operating marginBottom 16%
- Accruals (lower is better)Bottom 24%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 3%
- Free-cash-flow yieldBottom 2%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 9%
- 6-month returnBottom 12%
- 1-year return vs S&P 500Bottom 5%
- Distance from 52-week highBottom 12%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 30%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 34%
- Upside to consensus price targetTop 19%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 35%
- Maximum drawdown, 3 yearsBottom 1%
- Beta vs S&P 500 (lower is better)Bottom 31%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 74.8% | 196.0% | ↑ |
| Gross margin | 29.3% | 80.2% | ↑ |
| Operating margin | -838.0% | -568.4% | ↑ |
| FCF margin | -685.6% | -549.4% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 196.0% | 74.8% | ↑ | Top 7% |
| Gross margin | 80.2% | 29.3% | ↑ | Top 30% |
| Operating margin | -568.4% | -838.0% | ↑ | Bottom 16% |
| Net margin | -548.6% | -828.2% | ↑ | — |
| Free-cash-flow margin | -549.4% | -685.6% | ↑ | — |
| Return on invested capital | -74.0% | — | Bottom 16% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -1.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 20.7%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -146.1 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -150.29%
- Shareholder yield
- -150.29%
- Share count change, 1 year
- +127.0%
- Share count change, 3-year CAGR
- +42.4%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 10, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -8.4%
- Average 2-day reaction, last 8
- +8.0%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $27.00
- Target vs current price
- +203.0%
- Analysts with a rating
- 7
- Share rating Buy or Strong Buy
- 86%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 10, 2026 | +7.6% | +4.7% | +5.7% | +9.2% | — |
| May 11, 2026 | -15.4% | +0.1% | +11.7% | -16.9% | -20.1% |
| Mar 12, 2026 | -25.9% | -4.1% | +1.5% | -7.0% | -20.8% |
| Nov 10, 2025 | +0.0% | -0.9% | -6.5% | +17.0% | -12.1% |
| Aug 12, 2025 | -24.5% | +32.9% | -10.9% | -42.6% | -61.0% |
| May 12, 2025 | +12.1% | +1.9% | +48.7% | +108.2% | +142.3% |
| Mar 18, 2025 | -56.8% | +26.1% | +87.4% | -0.8% | +131.6% |
| Nov 12, 2024 | +88.7% | +3.3% | -5.2% | +40.1% | -14.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 10, 2026 | -$2.44 | -$2.64 | +7.6% | $13.5M |
| May 11, 2026 | -$2.93 | -$2.54 | -15.4% | $6.9M |
| Mar 12, 2026 | -$3.98 | -$3.16 | -25.9% | $5.4M |
| Nov 10, 2025 | -$3.59 | -$3.59 | +0.0% | $3.3M |
| Aug 12, 2025 | -$3.86 | -$3.10 | -24.5% | $2.0M |
| May 12, 2025 | -$2.84 | -$3.23 | +12.1% | $2.4M |
| Mar 18, 2025 | -$9.77 | -$6.23 | -56.8% | $2.6M |
| Nov 12, 2024 | -$23.00 | -$203.00 | +88.7% | $2.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -112.57% | — | — | Bottom 2% |
| Earnings yield | -148.60% | — | — | Bottom 3% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -3.7%
- 200-day average slope (20 days)
- -4.5%
- Distance from 50-day average
- -23.5%
- Distance from 200-day average
- -34.0%
- RSI (14)
- 21.8
- Relative volume
- 1.86×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 64.4%
- Volatility vs own 5-year history
- 6th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.50
- Correlation with S&P 500
- 0.13
- Current drawdown from 1-year high
- -64.0%
- Maximum drawdown, 3 years
- -99.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 11, 2021 | Mar 3, 2025 | -100.0% | 1017 days | Not yet recovered |
| Sep 29, 2020 | Nov 9, 2020 | -41.1% | 29 days | 43 days (Jan 12, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $142.0M
- EPS, diluted (TTM)
- -$13.24
- Revenue (TTM)
- $29.1M
- 52-week range
- $8.69 – $25.40
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $7.8M | $10.1M | $13.1M |
| Gross profit | $0 | $0 | $3.0M | $2.3M | $4.5M |
| Operating income | -$92.3M | -$112.1M | -$118.4M | -$136.7M | -$125.7M |
| Net income | -$92.3M | -$110.2M | -$116.7M | -$130.0M | -$124.0M |
| EPS (diluted) | -$163,968.00 | -$811.68 | -$6,368.84 | -$176.60 | -$14.57 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8M | $2.6M | $2.4M | $2.0M | $3.3M | $5.4M | $6.9M | $13.5M |
| Net income | -$14.2M | -$22.1M | -$16.8M | -$28.3M | -$32.0M | -$46.9M | -$40.2M | -$40.6M |
| EPS (diluted) | -$0.23 | -$9.77 | -$2.84 | -$3.86 | -$3.59 | -$4.28 | -$2.93 | -$2.44 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$75.6M | -$98.1M | -$102.0M | -$60.9M | -$99.8M |
| Capital expenditure | -$35.3M | -$48.1M | -$7.9M | -$120,000 | -$3.4M |
| Free cash flow | -$110.9M | -$146.2M | -$109.9M | -$61.0M | -$103.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $212.4M | $47.3M | $5.0M | $140.2M | $224.2M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $176.2M
- Total assets
- $254.1M
- Total liabilities
- $31.8M
- Total debt
- $1.3M
- Net debt
- -$175.0M
- Shareholders’ equity
- $222.3M
As of Jun 30, 2026 (filed Aug 10, 2026).
Short interest
- Shares sold short
- 2,838,419
- Days to cover
- 8.14
- Change vs previous report
- -8.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Feb 5, 2025
- 1-for-100
- Jun 10, 2024
- 1-for-32
- May 10, 2023
- 4-for-25
- May 17, 2022
- 1-for-32
- Nov 1, 2019
- 1-for-10